

Figure S2 miR-105 and miR-93-3p promote cellular migration but not proliferation. E Indicated miRNAs expression levels were examined in the independent cohort (GSE40267, N = 173), which contained 94 TNBC, 79 non-TNBC. The correlation between indicated miRNAs and overall survival in (C) 204 TNBC patients and (D) 1095 non-TNBC patients was analyzed by Kaplan-Meier analysis. B Elevated expression of miR-301b, miR-181a-3p, miR-105, and miR-93 were individually associated with poor overall survival in 1095 non-triple negative breast cancer patients by Kaplan-Meier analysis. A Identification of dysregulated miRNAs in TNBC compared with non-TNBC using Student t test. Additional file 1: Figure S1: Association between identified miRNAs and overall survival in TNBC and non-TNBC patients.
